Urgently Feeding America's Babies Act of 2022 This bill addresses a shortage in the domestic supply of infant formula. Specifically, the bill directs the President to immediately use existing authorities under the Defense Production Act of 1950 to ensure the supply of infant formula. That act confers upon the President a broad set of authorities to influence domestic industry in order to provide essential materials and goods needed for the national defense. In addition, the Food and Drug Administration must (1) establish, within 15 days, a process to allow importation of infant formula from the European Union; and (2) publish safety guidelines for imported infant formula.
Rep. Vern Buchanan
Sponsored bills
This resolution condemns the unauthorized leak of a draft Supreme Court opinion concerning abortion and the related violence, property damage, and attempted intimidation of Supreme Court Justices by activists. It also encourages the enforcement of federal criminal laws that prohibit protests and picketing outside of the homes of federal judges, jurors, witnesses, and others involved in the U.S. court system.
Benjamin Berell Ferencz Congressional Gold Medal Act This bill provides for the award of a Congressional Gold Medal to Benjamin Berell Ferencz in recognition of his service to the United States and the international community during the post-World War II Nuremberg trials and his lifelong advocacy for international criminal justice and the rule of law.
Maddy summaryThis bill prohibits using federal funds to establish a Disinformation Governance Board under the Department of Homeland Security. It directly affects the DHS by blocking any allocation of taxpayer money for creating this board. The key provision is a funding restriction that prevents the board's formation, requiring Congress to specifically authorize such spending if desired. The bill does not address disinformation policies or content, only the funding mechanism for the proposed board.
Maddy summaryThis bill prohibits the use of federal funds to establish or operate a Disinformation Governance Board under the Department of Homeland Security. It directly affects the Department of Homeland Security by blocking funding for this specific board, preventing its creation or activities. The measure restricts how existing federal appropriations can be applied, without altering other funding mechanisms.
This joint resolution nullifies the rule issued by the Centers for Disease Control and Prevention on February 3, 2021, that requires the use of face masks on planes, trains, buses, and other public conveyances and at transportation hubs to prevent the transmission of COVID-19.
Infectious Disease Therapies Research and Innovation Act of 2022 This bill exempts from the definition of passive activity , for purposes of the passive loss tax rules, any qualified medical research activity of a specified medical research small business pass-thru entity. The bill defines specified medical research small business pass-thru entity as any domestic pass-thru entity if more than 80% of such entity's expenditures on research are paid or incurred in connection with qualified medical research activities and the gross receipts of such entity for the taxable year are less than $1 million.
American Innovation Act of 2022 This bill revises the tax treatment of business start-up or organizational expenditures. Specifically, it allows an election to deduct such expenditures in an amount equal to the lesser of the aggregate amount of such expenditures incurred by an active trade of business, or $20,000, reduced by the amount by which such aggregate amount exceeds $120,000. The remaining amount of such expenditures shall be amortized over the 180 month period after the trade or business begins. The bill also revises the tax treatment of partnership syndication fees and start-up net operating losses and tax credits after an ownership change.
This bill expands the tax credit for increasing research activities to add a new credit amount equal to 14% of specified medical research expenditures. The bill defines specified medical research expenditures as amounts paid or incurred for research with respect to any qualified countermeasure (i.e., a drug, biological product, or device determined to be a priority in protecting against harm from a biological agent or adverse health condition).
This bill allows for the refundability of a portion of the tax credit for increasing research activities for small businesses (gross receipts not exceeding $1 million) engaged in specified medical research. Under the Public Health Service Act, specified medical research means research with respect to qualified countermeasures (i.e., a drug, biological product, or device for preventing harm from any biological agent or from a condition that may result in adverse health consequences or death).